ROYCE & ASSOCIATES LPROYCE & ASSOCIATES LP

Institutional investor · Portfolio as of Q3 2022

SEC EDGAR SourceSEC Filings

Top Holdings929 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ARCOSA INC

1.7M$99.2M1.1%$38.96+45.36%
15 qtrssince 2019-Q1
Decreased
0

KENNEDY-WILSON HOLDINGS INC

5.9M$90.8M1.0%$14.18-11.85%
15 qtrssince 2019-Q1
Increased
53

INNOSPEC INC

1M$89.8M1.0%$79.57+2.73%
15 qtrssince 2019-Q1
Decreased
0

KADANT INC

501,426$83.6M0.9%$93.86+74.37%
15 qtrssince 2019-Q1
Increased
44

VALMONT INDUSTRIES

307,192$82.5M0.9%$129.04+103.96%
15 qtrssince 2019-Q1
Decreased
0
894,511$80.7M0.9%$83.18+8.83%
15 qtrssince 2019-Q1
Increased
42
ALALDelisted

AIR LEASE CORP

2.6M$79.5M0.9%$32.25-8.02%
15 qtrssince 2019-Q1
Increased
42

ZIFF DAVIS INC

1.1M$78.4M0.9%$91.16-23.53%
15 qtrssince 2019-Q1
Decreased
0

KULICKE & SOFFA INDUSTRIES

2M$75.8M0.9%$25.37+43.43%
15 qtrssince 2019-Q1
Decreased
0

SEI INVTS CO

1.5M$71.3M0.8%$54.04-10.70%
15 qtrssince 2019-Q1
Increased
42

FORRESTER RESH INC

1.9M$68.4M0.8%$37.45-5.06%
15 qtrssince 2019-Q1
Increased
45

MARCUS & MILLICHAP INC

2.1M$67.4M0.8%$35.74-14.58%
15 qtrssince 2019-Q1
Increased
53

MKS INC

802,353$66.3M0.7%$95.04-13.02%
15 qtrssince 2019-Q1
Increased
42

LINDSAY CORP

460,858$66M0.7%$89.75+53.55%
15 qtrssince 2019-Q1
Decreased
0

RALPH LAUREN CORP

765,302$65M0.7%$89.84-8.59%
10 qtrssince 2020-Q2
Increased
43
HAHAE

HAEMONETICS CORP MASS

874,808$64.8M0.7%$79.85-7.81%
12 qtrssince 2019-Q4
Increased
43

FORMFACTOR INC

2.6M$64.6M0.7%$31.96-20.35%
15 qtrssince 2019-Q1
Increased
47

LANDSTAR SYSTEM INC

445,883$64.4M0.7%$99.72+35.54%
15 qtrssince 2019-Q1
Decreased
0

LINCOLN ELECTRIC HOLDINGS

508,401$63.9M0.7%$76.67+58.25%
15 qtrssince 2019-Q1
Decreased
0

INTERPARFUMS INC

843,323$63.6M0.7%$55.39+23.34%
15 qtrssince 2019-Q1
Decreased
0
$8.8B
AUM
929
Positions
Q3 2022
Filing
Rating · 2.5
Quarterly Portfolio Change
-2%Q2'21$14.6B-8%Q3'21$13.4B+0%Q4'21$13.4B-12%Q1'22$11.8B-18%Q2'22$9.7B-9%Q3'22$8.8B
Activity profile
$ moved · Q3'22
New7%Increased32%Decreased50%Exited11%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 years
<1Q5%1-4Q9%1-2Y11%2Y+76%

ROYCE & ASSOCIATES LP manages $8.8B across 929 positions as of Q3 2022. Top holdings: ACA (1.1%), KW (1.0%), IOSP (1.0%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.

Q3 2022 Summary

Active quarter - 66 new positions, 73 exits, 313 increased. Top move: KW (INCREASED, conviction 53). Portfolio: $8.8B across 929 positions.

Top holdings by portfolio weight

Total AUM$9B
ACA1.12%
KW1.03%
IOSP1.01%
KAI0.95%
VMI0.93%
FWRD0.91%
AL0.90%
ZD0.89%
KLIC0.86%
SEIC0.81%
Other0.77%

Portfolio allocation by GICS sector

Sectors11
Industrials25.18%
Technology16.68%
Financial Services12.35%
Consumer Cyclical12.33%
Unknown10.04%
Basic Materials6.83%
Healthcare6.27%
Real Estate3.26%
Consumer Defensive2.81%
Communication Services2.55%
Other1.69%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Industrials, Technology, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record69
Conviction31
Concentration14
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BFSTBFSTBUSINESS FIRST BANCSHARES IN
Q3 2024 Q2 2026+581,481 shares+$21M
8Q
CVLGCVLGCOVENANT LOGISTICS GROUP INC
Q3 2024 Q2 2026+275,648 shares+$11.8M
8Q
LABLABSTANDARD BIOTOOLS INC
Q3 2024 Q2 2026+4.2M shares+$3.2M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used